Thimerosal in swine flu vaccines stirs fresh controversy; Transplant/vaccine combo may be best bet against leukemia;

Swine Flu Vaccines

An advocacy group's attempt to prevent the U.S. government from giving swine flu vaccine containing thimerosal to pregnant women has been rejected by a federal judge. Story

Worried that drug manufacturers are primarily interested in selling jabs to the developed world, South African officials say they have no choice but to develop their own swine flu vaccine. Report

A White House advisory panels warning that up to 90,000 swine flu deaths could occur is being regarded with some skepticism at the CDC. Report

CSL has begun its first human trial in the U.S. for a new swine flu vaccine. Story

The CDC is already urging parents to hustle out and make sure everyone in the clan gets vaccinated once a swine flu vaccination campaign is launched this fall. Story

Vaccine Research

Researchers say that a combination therapeutic cancer vaccine and stem cell transplant could be a better bet for patients with an aggressive form of leukemia. Release

Hawaii Biotech has initiated a Phase 1 clinical study with its monovalent dengue vaccine candidate. "This dengue clinical study is an important milestone in Hawaii Biotech's maturation as a clinical stage company. In addition it confirms the versatility of our subunit vaccine technology platform," said CEO Elliot Parks, Ph.D. "This Phase 1 study will also prepare us for the initial clinical testing of Hawaii Biotech's tetravalent dengue vaccine." Release

The Infectious Disease Research Institute has launched a clinical trial in Sudan to test its leishmaniasis vaccine candidate for post kala-azar dermal leishmaniasis, a complication of visceral leishmaniasis. Release

GenVec has landed a $2.5 million grant from the National Institute of Allergy and Infectious Diseases to support development of its vaccine vector  production technology. Release

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.